<p>In this episode, we continue our conversation with Dr. Nancy Smerkanich, Assistant Professor at the University of Southern California School of Pharmacy. Dr. Smerkanich shares her insights into current Emergency Use Authorizations, how sponsors and the agency are interacting, and the expected pressures of developing, producing and distributing products during the pandemic. (Part 2)</p>

In this episode, we continue our conversation with Dr. Nancy Smerkanich, Assistant Professor at the University of Southern California School of Pharmacy. Dr. Smerkanich shares her insights into current Emergency Use Authorizations, how sponsors and the agency are interacting, and the expected pressures of developing, producing and distributing products during the pandemic. (Part 2)

Emergency Use Authorizations During the COVID-19 Pandemic - Part 2

Regulatory submission professionals talking about all things regulatory. 
-What's the latest on electronic regulatory submissions?
-What do I need to know about CDISC compliant data packages?
-What are most teams doing to support Ad Promo submissions in eCTD format?
We'll talk about trends, best practices, and emerging regulations. We'll also interview leaders from across the industry to share perspectives and lessons learned. 
Join us!

Business

Regulatory submission professionals talking about all things regulatory. -What's the latest on electronic regulatory submissions? -What do I need to know about CDISC compliant data packages? -What are most teams doing to support Ad Promo submissions in eCTD format? We'll talk about trends, best practices, and emerging regulations. We'll also interview leaders from across the industry to share perspectives and lessons learned. Join us!

Share Emergency Use Authorizations During the COVID-19 Pandemic - Part 2

Sign up to save your podcasts

Emergency Use Authorizations During the COVID-19 Pandemic - Part 2

Emergency Use Authorizations During the COVID-19 Pandemic - Part 2